HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fumihiko Mouri Selected Research

mogamulizumab

10/2019Complete response following toxic epidermal necrolysis in relapsed adult T cell leukemia/lymphoma after haploidentical stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fumihiko Mouri Research Topics

Disease

4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 01/2013
2Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
10/2019 - 11/2012
2Fever (Fevers)
03/2013 - 11/2005
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2022
1Febrile Neutropenia
01/2021
1Neutropenia
01/2021
1Muscular Atrophy (Muscle Atrophy)
01/2021
1Lymphoma (Lymphomas)
01/2021
1Inherited Blood Coagulation Disorders
09/2020
1Stevens-Johnson Syndrome (Lyell's Syndrome)
10/2019
1Monoclonal Gammopathy of Undetermined Significance
04/2016
1Multiple Myeloma
04/2016
1Chromosome Aberrations (Chromosome Abnormalities)
01/2014
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2014
1Breakthrough Infections
03/2013
1Communicable Diseases (Infectious Diseases)
03/2013
1Mycoses (Diseases, Fungus)
03/2013
1Zygomycosis (Phycomycosis)
03/2013
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2013
1Cholecystitis
03/2009
1Inflammation (Inflammations)
01/2008
1T-Cell Leukemia (Leukemia, T Cell)
12/2007
1Chills
11/2005
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2005
1Erythema
11/2005

Drug/Important Bio-Agent (IBA)

2Lenalidomide (CC 5013)FDA Link
10/2019 - 04/2016
1defibrotideIBA
01/2022
1Inotuzumab OzogamicinIBA
01/2022
1Tyrosine Kinase InhibitorsIBA
02/2021
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2021
1Serum AlbuminIBA
01/2021
1Factor V (Coagulation Factor V)IBA
09/2020
1MethylprednisoloneFDA LinkGeneric
10/2019
1mogamulizumabIBA
10/2019
1Intravenous Immunoglobulins (IVIG)FDA Link
10/2019
1Immunosuppressive Agents (Immunosuppressants)IBA
10/2019
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2019
1Voriconazole (Vfend)FDA LinkGeneric
03/2013
1Pharmaceutical PreparationsIBA
03/2013
1Polymethyl Methacrylate (Sol)IBA
03/2013
1Histones (Histone)IBA
01/2008
1HMGB1 Protein (HMG1)IBA
01/2008
1Proteins (Proteins, Gene)FDA Link
01/2008
1DNA-Binding Proteins (DNA Binding Protein)IBA
01/2008
1NF-kappa B (NF-kB)IBA
12/2007
1Imatinib Mesylate (Gleevec)FDA Link
11/2005

Therapy/Procedure

6Therapeutics
01/2022 - 11/2005
4Transplantation
01/2022 - 11/2012
3Stem Cell Transplantation
01/2021 - 03/2013
2Drug Therapy (Chemotherapy)
01/2021 - 01/2013
1Hematopoietic Stem Cell Transplantation
01/2022
1Length of Stay
01/2021
1Cell Transplantation
10/2019
1Radiotherapy
04/2016
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
01/2013
1Cardiopulmonary Resuscitation (CPR)
03/2009